Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 PK in severe renal impairment
NCT04024332Phase 1Completed
- Sponsor
- Idorsia
- Start
- Sep 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of daridorexant in Insomnia (2 arms), sponsored by Idorsia. Primary endpoint: Area under the plasma concentration-time curve from time zero to infinity up to 4 days. Started Sep 2019; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04024332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04024332.